Scinovex
article

RISE IN PLASMA CONCENTRATION OF ALDOSTERONE DURING LONG-TERM ANGIOTENSIN II SUPPRESSION

Journal of Endocrinology · 1981 · Vol. 91(3) · pp. 457–465

Abstract

The plasma concentration of aldosterone was followed in seven hypertensive patients before and during long-term angiotensin II suppression with the orally active angiotensin-I-converting-enzyme inhibitor, captopril. The plasma concentration of aldosterone decreased initially from 74 to 21 pg/ml (P less than 0.05) after 1 month of administration of captopril. Thereafter the plasma concentration of aldosterone began to rise and after 1 year reached a level of 165 pg/ml. During long-term captopril therapy the plasma renin activity remained increased and the plasma angiotensin II concentration suppressed. The mechanism responsible for the late rise of the plasma concentration of aldosterone during long-term angiotensin II suppression with captopril remains to be elucidated. A sizeable and lasting hypotensive effect was observed in all patients.

Blood Pressure and Hypertension StudiesHormonal Regulation and HypertensionReceptor Mechanisms and SignalingCaptoprilAldosteroneInternal medicineEndocrinologyRenin–angiotensin systemAngiotensin IIPlasma renin activityChemistryAngiotensin-converting enzymePlasma concentration

MeSH terms

AdultAldosteroneAngiotensin IICaptoprilDepression, ChemicalFemaleHumansHypertensionMaleMiddle AgedProlineReninTime Factors
Citations
334
FWCI
1.60
field-weighted impact
References
0
Percentile
82%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.